Use of the Glucagon-Like Peptide-2 Analog, glepaglutide, in the Treatment of Patients with Short Bowel Syndrome

    Original languageEnglish
    PublisherFaculty of Health Sciences, University of Copenhagen
    Publication statusPublished - 2019

    Cite this